The ORMP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ORMP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ORMP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ORMP Detailed Price Forecast - CNN Money||View ORMP Detailed Summary - Google Finance|
|View ORMP Detailed Summary - Yahoo! Finance||View ORMP Stock Research & Analysis - Zacks.com|
|View ORMP Trends & Analysis - Trade-Ideas||View ORMP Major Holders - Barrons|
|View ORMP Call Transcripts - NASDAQ||View ORMP Breaking News & Analysis - Seeking Alpha|
|View ORMP Annual Report - CompanySpotlight.com||View ORMP OTC Short Report - OTCShortReport.com|
|View ORMP Fundamentals - TradeKing||View ORMP SEC Filings - Bar Chart|
|View Historical Prices for ORMP - The WSJ||View Performance/Total Return for ORMP - Morningstar|
|View the Analyst Estimates for ORMP - MarketWatch||View the Earnings History for ORMP - CNBC|
|View the ORMP Earnings - StockMarketWatch||View ORMP Buy or Sell Recommendations - MacroAxis|
|View the ORMP Bullish Patterns - American Bulls||View ORMP Short Pain Metrics - ShortPainBot.com|
|View ORMP Stock Mentions - StockTwits||View ORMP Stock Mentions - PennyStockTweets|
|View ORMP Stock Mentions - Twitter||View ORMP Investment Forum News - Investor Hub|
|View ORMP Stock Mentions - Yahoo! Message Board||View ORMP Stock Mentions - Seeking Alpha|
|View Insider Transactions for ORMP - SECform4.com||View Insider Transactions for ORMP - Insider Cow|
|View ORMP Major Holdings Summary - CNBC||View Insider Disclosure for ORMP - OTC Markets|
|View Insider Transactions for ORMP - Yahoo! Finance||View Institutional Holdings for ORMP - NASDAQ|
|View ORMP Stock Insight & Charts - FinViz.com||View ORMP Investment Charts - StockCharts.com|
|View ORMP Stock Overview & Charts - BarChart||View ORMP User Generated Charts - Trading View|
Oramed Granted Japanese Patent for GLP-1 Analog Capsule
Posted on Tuesday July 24, 2018
NEW YORK, July 24, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent titled, "Methods and Compositions for Oral Administration of Exenatide." The patent covers Oramed's proprietary invention of an oral glucagon-like peptide-1 (GLP-1) analog. Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (PODTM) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center.
Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4
Posted on Tuesday July 17, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 16) Arcus Biosciences Inc (NYSE: RCUS ) BioLife Solutions Inc (NASDAQ: ...
Oramed: Fiscal 3Q Earnings Snapshot
Posted on Thursday July 12, 2018
The Jerusalem-based company said it had a loss of 30 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...
Oramed Announces Closing of $18.1 Million Registered Direct Offering
Posted on Friday July 06, 2018
NEW YORK, July 6, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the closing of its previously-announced registered direct offering with several healthcare-focused institutional investors. Oramed has sold $18.1 million of shares of common stock and warrants to purchase shares of common stock at a combined price of $6.25 per share and related warrant. The securities described above were offered pursuant to a shelf registration statement (File No. 333-215525), which was declared effective by the United States Securities and Exchange Commission ("SEC") on February 2, 2017.